BIO

CEO Polpharma Group. He holds a degree in Economics and has been working in emerging industries, such as information technology in Switzerland and United States and in emerging markets such as Singapore, Poland and CIS countries. Since the mid-nineties he has successfully managed complex and strategic transactions in and outside of Poland in the pharmaceutical industry, FMCG and media and has been a member of the supervisory board of several of those companies. He is associated with Polpharma Group since 2000 and was appointed President of the Management Board in June 2016.

In Impact’18 Agenda

Day I 13.06.2018 Wednesday 11:45 – 11:55
Stage: S1
Track:
Keynote
“How to use the power of innovation to satisfy the patient needs?”

---

Day I 13.06.2018 Wednesday 17:05 – 17:30
Stage: S2
Track: biotechnology & digital health
Moderated discussion
“Act now! Building a competitive Polish biotechnology ecosystem “

---